Generation Bio Co Stock Working Capital
| GBIO Stock | USD 3.24 0.12 3.85% |
Generation Bio Co fundamentals help investors to digest information that contributes to Generation Bio's financial success or failures. It also enables traders to predict the movement of Generation Stock. The fundamental analysis module provides a way to measure Generation Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Generation Bio stock.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | 232.7 M | 219.4 M | |
| Change In Working Capital | 53.5 M | 56.2 M |
Generation | Working Capital |
Generation Bio Co Company Working Capital Analysis
Generation Bio's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Generation Bio Working Capital | 232.7 M |
Most of Generation Bio's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Generation Bio Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generation Working Capital Driver Correlations
Understanding the fundamental principles of building solid financial models for Generation Bio is extremely important. It helps to project a fair market value of Generation Stock properly, considering its historical fundamentals such as Working Capital. Since Generation Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Generation Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Generation Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Generation Capital Surpluse
Capital Surpluse |
|
According to the company's disclosures, Generation Bio Co has a Working Capital of 232.7 M. This is 45.33% lower than that of the Biotechnology sector and 56.8% lower than that of the Health Care industry. The working capital for all United States stocks is 84.26% higher than that of the company.
Generation Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Generation Bio's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Generation Bio could also be used in its relative valuation, which is a method of valuing Generation Bio by comparing valuation metrics of similar companies.Generation Bio is currently under evaluation in working capital category among its peers.
Generation Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Generation Bio from analyzing Generation Bio's financial statements. These drivers represent accounts that assess Generation Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Generation Bio's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.1B | 772.7M | 398.6M | 228.4M | 262.7M | 249.5M | |
| Enterprise Value | 1.1B | 709.8M | 104.3M | 216.9M | 249.5M | 237.0M |
Generation Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Generation Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Generation Bio's managers, analysts, and investors.Environmental | Governance | Social |
Generation Fundamentals
| Return On Equity | -0.82 | ||||
| Return On Asset | -0.22 | ||||
| Operating Margin | (5.10) % | ||||
| Current Valuation | 80.22 M | ||||
| Shares Outstanding | 66.53 M | ||||
| Shares Owned By Insiders | 14.55 % | ||||
| Shares Owned By Institutions | 83.29 % | ||||
| Number Of Shares Shorted | 1.62 M | ||||
| Price To Book | 1.21 X | ||||
| Price To Sales | 41.66 X | ||||
| Revenue | 5.9 M | ||||
| EBITDA | (133.3 M) | ||||
| Net Income | (126.61 M) | ||||
| Cash And Equivalents | 301.17 M | ||||
| Cash Per Share | 5.07 X | ||||
| Total Debt | 97.89 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 17.93 X | ||||
| Book Value Per Share | 1.99 X | ||||
| Cash Flow From Operations | (52.74 M) | ||||
| Short Ratio | 7.40 X | ||||
| Earnings Per Share | (2.55) X | ||||
| Target Price | 7.5 | ||||
| Number Of Employees | 174 | ||||
| Beta | 2.87 | ||||
| Market Capitalization | 203.58 M | ||||
| Total Asset | 374.76 M | ||||
| Retained Earnings | (571.38 M) | ||||
| Working Capital | 232.7 M | ||||
| Net Asset | 374.76 M |
About Generation Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Generation Bio Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Generation Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Generation Bio Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Generation Stock
When determining whether Generation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Generation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Generation Bio Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Generation Bio Co Stock:Check out Generation Bio Piotroski F Score and Generation Bio Altman Z Score analysis. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.55) | Revenue Per Share 0.151 | Return On Assets (0.22) | Return On Equity (0.82) |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.